It’s crazy how cheap some of these healthcare names are like $CNC Centene is down -70% from all time highs despite being up 15% from August 7th lows @ $25😮‍💨👀 Prior to cutting guidance & earnings, fair value was sitting around $90/share. Now, fair value still sits at

💉 Healthcare insiders are BUYING — at levels not seen in 20+ years. When execs invest heavily in their own companies, it’s worth watching: $UNH: $25M+ $LLY: $4.5M+ $ELV: $2.8M+ $CVS: $2.1M+ $TMDX: $1.9M (CEO) $HUM: $1.5M (CEO) $SIGI: $1.3M+ $CNC: $700K+ $NVO: $120K (Director)

Representative Marjorie Greene added $NVO

$NVO An easy 3x your Money in less than 2 years.

$SNAP This bad boy one day will bounce Huge. They are accumulating and this stock will have their 2-3 days when goes parabolic UP. Only is needed a little patience before the real Pump.

$NVO #NVO The most clear Risk Reward Play in the Market right now where Tech and other sectors are heated and HealthCare is clearly undervalued. This bargain price not gonna last too much.

$SNAP #SNAP We are approaching to the Capitulation of Weak Hands after a Fakeout under 7$. The ones Adiing/Buying here will make Big Profits. Adding some More. FEW!!

$SNAP #SNAP YOU have been Warned!! Have you been buying enough for the BIG PUMP Incoming?

$SNAP While others are giving up, that’s when I wake up. $SNAP is sitting right at a massively important liquidity gap (marked in yellow) and building resistance. Entry opportunity? Hell yeah!

$SNAP #SNAP If YOU are not buying at this price, I must suppose you hate money. 2 Digit Stock again Soon.

Øyvind Fjell, portfolio manager at Eika and among $NVO 100 largest shareholders, has recently bought shares worth around 150 million DKK, he told Danish newspaper Børsen. “Novo no longer needs to deliver extraordinary results for the stock to rise. It’s now cheap enough that

🚨HUGE RISK ALERT: $HIMS BOOKMARK THIS! 📑 Why I think $HIMS is going to have a huge drop, and I expect massive insider selling.. As far as I know $NVO ( + $LLY) have PATENT for its drugs and nobody is allowed to: 1. Manufacture 2. Market 3. Sell Products that are: 1. The

New CEO, cost controls, and 132 lawsuits against copycats show $NVO means business. Pipeline with CagriSema, Amylin, and new partnerships. New plants scale production for increasing demand. Buy, hold, get rich.

$BBAI #BBAI Big Pump Incoming.

$BBAI #BBAI Back to 8$ on Turbo Mode.

$SGD #SGD Buying the Dip at the Daily 200 SMA. Be sure this gonna ride UP Huge as $OPEN has did in the last sessions.

$ADBE #ADBE This dip is a Gift. Adding.

$NVO shared new data on its next-generation obesity drug cagrilintide. Patients lost an average of 12.5kg (≈11.8% of body weight) after 68 weeks, compared with just 2.5kg on placebo. About 1 in 3 people achieved 15%+ weight loss. The drug was generally well tolerated, with

$NVO #NVO Adding More dirty Cheap Shares!

$BBAI #BBAI My Buy Zone Working nicely. Don't say YOU have been not warned. Next targets: 6,20 & 6,90